Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

PURPOSE OF REVIEW: The treatment options for high-risk non-muscle invasive bladder cancer (NMIBC), particularly following BCG, remain limited. We highlight recent, promising therapies for high-risk NMIBC. RECENT FINDINGS: Several therapies utilizing different mechanisms of action have demonstrated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Hussein Al Awamlh, Bashir, Chang, Sam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Genitourinary Cancers (Dp Petrylak and Jw Kim, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791638/
https://www.ncbi.nlm.nih.gov/pubmed/36571706
http://dx.doi.org/10.1007/s11912-022-01350-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791638/
https://www.ncbi.nlm.nih.gov/pubmed/36571706
http://dx.doi.org/10.1007/s11912-022-01350-9

Ejemplares similares